0000899243-20-030488.txt : 20201105 0000899243-20-030488.hdr.sgml : 20201105 20201105180858 ACCESSION NUMBER: 0000899243-20-030488 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201103 FILED AS OF DATE: 20201105 DATE AS OF CHANGE: 20201105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Temasek Holdings (Private) Ltd CENTRAL INDEX KEY: 0001021944 STATE OF INCORPORATION: U0 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39662 FILM NUMBER: 201291836 BUSINESS ADDRESS: STREET 1: 60B ORCHARD ROAD #06-18 TOWER 2 STREET 2: THE ATRIUM@ORCHARD CITY: SINGAPORE STATE: U0 ZIP: 238891 BUSINESS PHONE: 65 6828 6828 MAIL ADDRESS: STREET 1: 60B ORCHARD ROAD #06-18 TOWER 2 STREET 2: THE ATRIUM@ORCHARD CITY: SINGAPORE STATE: U0 ZIP: 238891 FORMER NAME: FORMER CONFORMED NAME: TEMASEK HOLDINGS (PRIVATE) LTD DATE OF NAME CHANGE: 20050912 FORMER NAME: FORMER CONFORMED NAME: TEMASEK HOLDINGS LTD DATE OF NAME CHANGE: 19960829 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SQZ Biotechnologies Co CENTRAL INDEX KEY: 0001604477 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462431115 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 ARSENAL YARDS BLVD., STE. 210 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-898-8824 MAIL ADDRESS: STREET 1: 200 ARSENAL YARDS BLVD., STE. 210 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-03 0 0001604477 SQZ Biotechnologies Co SQZ 0001021944 Temasek Holdings (Private) Ltd 60B ORCHARD ROAD, #06-18 TOWER 2 THEATRIUM@ORCHARD SINGAPORE U0 233891 SINGAPORE 0 0 1 0 Common Stock 2020-11-03 4 C 0 1888924 A 1888924 I See note Common Stock 2020-11-03 4 P 0 625000 16.00 A 2513924 I See note Series D Preferred Stock 2020-11-03 4 C 0 1888924 0.00 D Common Stock 1888924 0 I See note The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis upon the closing of the Issuer's initial public offering and had no expiration date. The shares are held of record by Elbrus Investments Pte. Ltd. ("Elbrus"). Elbrus is a direct wholly owned subsidiary of Temasek Life Sciences Private Limited, which in turn is a direct wholly owned subsidiary of Fullerton Management Pte Ltd, which in turn is a direct wholly owned subsidiary of Temasek Holdings (Private) Limited ("Temasek"). Therefore, Temasek may be deemed to beneficially own the shares held of record by Elbrus. The shares are held of record by V-Sciences Investments Pte Ltd. ("V-Sciences"). V-Sciences is a direct wholly owned subsidiary of Temasek Life Sciences Private Limited, which in turn is a direct wholly owned subsidiary of Fullerton Management Pte Ltd, which in turn is a direct wholly owned subsidiary of Temasek Holdings (Private) Limited ("Temasek"). Therefore, Temasek may be deemed to beneficially own the shares held of record by V-Sciences. TEMASEK HOLDINGS (PRIVATE) LIMITED By: /s/ Gregory Tan, in his capacity as Authorized Signatory 2020-11-05